{"id":794944,"date":"2026-03-10T17:34:02","date_gmt":"2026-03-10T17:34:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=794944"},"modified":"2026-03-10T17:34:02","modified_gmt":"2026-03-10T17:34:02","slug":"blood-collection-devices-market-surges-to-1302-billion-by-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/blood-collection-devices-market-surges-to-1302-billion-by-2030_794944.html","title":{"rendered":"Blood Collection Devices Market Surges to $13.02 Billion by 2030"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/upload\/2026\/03\/1773137769.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Blood Collection Devices Market Surges to $13.02 Billion by 2030\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/03\/1773137769.jpg\" alt=\"Blood Collection Devices Market Surges to $13.02 Billion by 2030\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles &#038; Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostics, Therapeutics), End User (Hospitals, Blood Banks) &#8211; Global Forecast to 2030 <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Advanced Blood Collection Technologies and Preventive Healthcare Initiatives Reshape Clinical Diagnostics and Patient Care Across Global Healthcare Systems<\/div>\n<p style=\"text-align: justify;\">The worldwide <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/blood-collection-market-39733117.html\" target=\"_blank\">blood collection devices market<\/a> is expanding rapidly, valued at USD 9.13 billion in 2025 and projected to reach USD 13.02 billion by 2030, growing at a CAGR of 7.4%. This growth reflects fundamental shifts in global healthcare as organizations increasingly prioritize advanced diagnostic capabilities and patient safety. Rising infectious diseases, chronic conditions like diabetes and cardiovascular disorders, and growing trauma cases are driving urgent demand for reliable blood collection solutions across hospitals, diagnostic laboratories, and healthcare facilities worldwide.<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure: <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=39733117&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=39733117<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>WHY THIS MATTERS FOR YOUR ORGANIZATION<\/strong><\/p>\n<p style=\"text-align: justify;\">The global emphasis on preventive healthcare and early disease detection is reshaping diagnostic workflows. Healthcare leaders are investing in advanced blood collection devices to support routine health screenings, improve sample quality, and accelerate diagnostic accuracy. The emergence of liquid biopsy tests&mdash;which enable early disease detection through blood analysis&mdash;is further driving demand for sophisticated collection devices that preserve sample integrity. For C-suite executives, this represents a strategic opportunity to align infrastructure investments with cutting-edge diagnostic capabilities and improve patient outcomes.<\/p>\n<p style=\"text-align: justify;\"><strong>MARKET SEGMENTS DRIVING GROWTH<\/strong><\/p>\n<p style=\"text-align: justify;\">Blood collection tubes dominate the market, accounting for the largest revenue share due to widespread use in diagnostic testing and blood banking. Complementary products including needles, syringes, blood bags, and lancets complete the collection ecosystem. Diagnostic applications represent the primary market driver, as blood testing remains essential for disease identification and preventive screening. Manual collection methods remain foundational in cost-sensitive regions, while automated solutions are gaining adoption among leading healthcare systems offering enhanced safety and reduced contamination risks.<\/p>\n<p style=\"text-align: justify;\"><strong>WHERE DEMAND IS STRONGEST<\/strong><\/p>\n<p style=\"text-align: justify;\">Hospitals, ambulatory surgical centers, and nursing homes represent the largest end-user segment, driven by high patient volumes and surgical procedures. Diagnostic and pathology laboratories form a second major segment, as blood analysis underpins disease detection and prevention strategies. Blood banks maintain critical reliance on collection devices for efficient blood processing and storage. North America leads globally with robust healthcare infrastructure and strong adoption of advanced diagnostic technologies, while emerging regions are accelerating adoption as healthcare infrastructure expands and diagnostic awareness grows.<\/p>\n<p style=\"text-align: justify;\"><strong>KEY OPPORTUNITIES AND CHALLENGES<\/strong><\/p>\n<p style=\"text-align: justify;\">Technological innovations in blood collection&mdash;including minimally invasive, closed-system, and laser-assisted devices&mdash;are creating significant growth opportunities. Integration of automation, digital monitoring, and connectivity solutions reduces human error and streamlines laboratory workflows. However, elevated costs of automated systems pose barriers in developing markets, particularly for smaller healthcare facilities with budget constraints. Additionally, a critical shortage of skilled phlebotomists and trained laboratory technicians&mdash;especially in rural and resource-limited settings&mdash;threatens service quality and market expansion. Healthcare organizations must address these gaps through workforce training programs and strategic investment in automation.<\/p>\n<p style=\"text-align: justify;\"><strong>INDUSTRY LEADERS SHAPING THE MARKET<\/strong><\/p>\n<p style=\"text-align: justify;\">Major global players driving innovation include Fresenius Kabi AG (Germany), Becton, Dickinson and Company (United States), Terumo BCT, Inc. (Japan), Greiner Bio-One International GmbH (Austria), and Cardinal Health (United States). These organizations continue advancing collection device technology, expanding geographic reach, and establishing industry standards that shape clinical practice worldwide.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages: <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=39733117&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=39733117<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>STRATEGIC IMPERATIVE FOR DECISION-MAKERS<\/strong><\/p>\n<p style=\"text-align: justify;\">Healthcare organizations, diagnostic service providers, and equipment manufacturers that strategically invest in advanced collection infrastructure and workforce development will strengthen competitive positioning and improve clinical outcomes. The 7.4% CAGR expansion through 2030 represents both a clinical necessity and a compelling business opportunity. Rising disease prevalence, accelerating diagnostic demand, and technological innovation are creating sustained market tailwinds&mdash;making now the optimal time for C-suite executives to align capital investment with market momentum and position their organizations for sustainable growth.<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/needles-market-223979930.html\">Needles Market<\/a><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/blood-screening-market-267747042.html\">Blood Screening Market<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=blood-collection-devices-market-surges-to-1302-billion-by-2030\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/blood-collection-market-39733117.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/blood-collection-market-39733117.html<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=blood-collection-devices-market-surges-to-1302-billion-by-2030\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles &#038; Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostics, Therapeutics), End User (Hospitals, Blood Banks) &#8211; Global Forecast to 2030 Advanced Blood Collection Technologies and Preventive Healthcare &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/blood-collection-devices-market-surges-to-1302-billion-by-2030_794944.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-794944","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/794944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=794944"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/794944\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=794944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=794944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=794944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}